Weekly CEO Buys Highlight
Insiders invest in Neoleukin Therapeutics, Urstadt Biddle Properties, OPKO Health, Corporate Office Properties Trust and Provention Bio Continue reading… …read more […]
Insiders invest in Neoleukin Therapeutics, Urstadt Biddle Properties, OPKO Health, Corporate Office Properties Trust and Provention Bio Continue reading… …read more […]
Brian Hannasch has been the CEO of Alimentation Couche-Tard Inc. (TSE:ATD.B) since 2014. This report will, first… …read more […]
Don’t be complacent with your investments. Here’s one thing to remember before putting cash to work in stocks in the next decade. …read more […]
It hasn’t been the best quarter for Conformis, Inc. (NASDAQ:CFMS) shareholders, since the share price has fallen 29… …read more […]
Lockheed Martin Corp said on Monday it has reached its 2019 target to deliver 131 F-35 fighter jets to the United States and its allies, as the defense contractor built 47% more jets this year.
The world’s largest defense contractor said that in 2020 it aims to deliver 141 F-35s. The cost of the most common variation of the jet, the F-35A, is now $77.9 million, meeting the defense contractor’s $80 million goal a year earlier than planned, Lockheed said in a statement. The F-35 program, which currently makes up about 25% of Lockheed’s annual revenue, has long aimed at expanding the fleet to more than 3,000 jets and bringing the unit price of the F-35A below $80 million through efficiencies gained by bulk orders. …read more […]
(Bloomberg) — A retweet by President Donald Trump, naming the alleged whistle-blower whose complaint triggered the investigation that resulted in his impeachment, was restored to Twitter late Saturday.The post, originally from the handle @Surfermom77, was retweeted by Trump to his 68 million followers about midnight Friday and by Saturday morning was no longer visible in the president’s Twitter feed. CNN first reported late Saturday that the temporary removal followed a Twitter glitch that affected certain accounts, not deliberate action to delete the tweet by Trump or someone with access to his account.“Due to an outage with one of our systems, …read more […]
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is… …read more […]
Policymakers around the country are home for the holidays but the impact of their decisions are about to be felt in a few areas. …read more […]
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put… …read more […]
By buying an index fund, you can roughly match the market return with ease. But if you pick the right individual… …read more […]
Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll apply a basic… …read more […]
Ethereum research scientist Virgil Griffith, who was arrested last month for allegedly assisting North Korea in learning more about blockchain and cryptocurrencies, has been denied bail. Inner City Press reported the news Thursday, saying that the judge denied bail, citing Griffith’s text messages to his parents about renouncing his U.S. citizenship and setting up a […]The post Ethereum research scientist Virgil Griffith denied bail in North Korea case appeared first on The Block. …read more […]
It is a pleasure to report that the Catalyst Biosciences, Inc. (NASDAQ:CBIO) is up 38% in the last quarter. But that… …read more […]
HEXO (HEXO) traded down 20% on Boxing Day after the company had a surprise equity raise. Considering the company recently completed a sizable convertible debt offering, the move on an inopportune day to raise equity doesn’t offer a promising outlook for the stock of the struggling Canadian cannabis company.Boxing Day Equity OfferingOn December 26 or Boxing Day in Canada, HEXO announced a definitive agreement to sell 14,970,062 shares to institutional investors at an offering price of $1.67. The deal was an ~14% discount to market prices and raised gross proceeds of $25 million. In addition, the offering includes warrants to …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.